↓ Skip to main content

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
11 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
256 Dimensions

Readers on

mendeley
364 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd006504.pub2
Pubmed ID
Authors

Michal Rolinski, Chris Fox, Ian Maidment, Rupert McShane

Abstract

Previous Cochrane reviews have considered the use of cholinesterase inhibitors in both Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). The clinical features of DLB and PDD have much in common and are distinguished primarily on the basis of whether or not parkinsonism precedes dementia by more than a year. Patients with both conditions have particularly severe deficits in cortical levels of the neurotransmitter acetylcholine. Therefore, blocking its breakdown using cholinesterase inhibitors may lead to clinical improvement.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 364 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 1%
United States 2 <1%
Switzerland 2 <1%
Canada 1 <1%
Czechia 1 <1%
Netherlands 1 <1%
France 1 <1%
Belgium 1 <1%
Spain 1 <1%
Other 2 <1%
Unknown 348 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 62 17%
Researcher 54 15%
Student > Ph. D. Student 52 14%
Student > Master 47 13%
Student > Postgraduate 36 10%
Other 88 24%
Unknown 25 7%
Readers by discipline Count As %
Medicine and Dentistry 165 45%
Psychology 40 11%
Neuroscience 31 9%
Agricultural and Biological Sciences 20 5%
Nursing and Health Professions 13 4%
Other 52 14%
Unknown 43 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2018.
All research outputs
#2,110,104
of 14,549,400 outputs
Outputs from Cochrane database of systematic reviews
#4,787
of 11,015 outputs
Outputs of similar age
#16,587
of 122,084 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 124 outputs
Altmetric has tracked 14,549,400 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,015 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,084 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.